Critically, NRF2 has been shown to play an important role in mitigating the onset and progression of several neurodegenerative diseases, including Parkinson’s disease (PD), Alzheimer’s disease (AD), Huntington’s disease (HD), and Multiple sclerosis (MS) (Cuadrado, 2022). The gene discussed is NFE2L2; the disease is myeloid sarcoma.